FLAC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flac, and when can generic versions of Flac launch?
Flac is a drug marketed by Patrin and is included in one NDA.
The generic ingredient in FLAC is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flac
A generic version of FLAC was approved as fluocinolone acetonide by TARO on April 27th, 1982.
Summary for FLAC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 4,942 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLAC at DailyMed |
Pharmacology for FLAC
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FLAC
US Patents and Regulatory Information for FLAC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patrin | FLAC | fluocinolone acetonide | OIL/DROPS;OTIC | 210736-001 | Apr 11, 2018 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |